Literature DB >> 16586511

Expression of viral capsid protein antigen against Epstein-Barr virus in plastids of Nicotiana tabacum cv. SR1.

Maggie Y T Lee1, Yuanxiang Zhou, Raymond W M Lung, Mee-Len Chye, Wing-Kin Yip, Sze-Yong Zee, Eric Lam.   

Abstract

Epstein-Barr virus (EBV) infects nearly 90% of adults worldwide and is the pathogenic source of a broad spectrum of malignancies originating from lymphoid and epithelial cells. Currently, no vaccine has been developed to immunologically inactivate this virus. In infected patients, anti-EBV viral capsid antigen (VCA) immunoglobins represent some of the useful diagnostic markers for carcinoma development. To demonstrate that the EBV VCA antigen can be produced in plants, the plastid genome of tobacco (Nicotiana tabacum cv. SR1) was transformed with a VCA-expressing cassette. The EBV VCA mRNA was actively transcribed in the transplastomic plants and antigen production was detected. This study indicates that plastid transformation could be a promising strategy in EBV VCA antigen production. Copyright 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586511     DOI: 10.1002/bit.20948

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  Expression of the truncated tissue plasminogen activator (K2S) gene in tobacco chloroplast.

Authors:  Maryam Abdoli-Nasab; Mokhtar Jalali-Javaran; Rosa M Cusidó; Javier Palazón; Amin Baghizadeh; Houshang Alizadeh
Journal:  Mol Biol Rep       Date:  2013-10-11       Impact factor: 2.316

Review 2.  The green vaccine: A global strategy to combat infectious and autoimmune diseases.

Authors:  Abdoreza Davoodi-Semiromi; Nalapalli Samson; Henry Daniell
Journal:  Hum Vaccin       Date:  2009-07-23

Review 3.  Plastid genetic engineering in Solanaceae.

Authors:  Jelli Venkatesh; Se Won Park
Journal:  Protoplasma       Date:  2012-03-07       Impact factor: 3.356

4.  Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco.

Authors:  Igor Kolotilin; Angelo Kaldis; Bert Devriendt; Jussi Joensuu; Eric Cox; Rima Menassa
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 5.  The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts.

Authors:  Nicolau B da Cunha; Nicole B Cobacho; Juliane F C Viana; Loiane A Lima; Kamila B O Sampaio; Stephan S M Dohms; Arthur C R Ferreira; César de la Fuente-Núñez; Fabrício F Costa; Octávio L Franco; Simoni C Dias
Journal:  Drug Discov Today       Date:  2016-11-23       Impact factor: 7.851

Review 6.  Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.

Authors:  Reynald Tremblay; David Wang; Anthony M Jevnikar; Shengwu Ma
Journal:  Biotechnol Adv       Date:  2009-12-02       Impact factor: 14.227

7.  Expression of a multi-epitope DPT fusion protein in transplastomic tobacco plants retains both antigenicity and immunogenicity of all three components of the functional oligomer.

Authors:  Ruth Elena Soria-Guerra; Angel G Alpuche-Solís; Sergio Rosales-Mendoza; Leticia Moreno-Fierros; Elise M Bendik; Luzmila Martínez-González; Schuyler S Korban
Journal:  Planta       Date:  2009-03-21       Impact factor: 4.116

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.